Tag: Prescription Drugs
Baricitinib Reduces Mortality in Critically Ill Adults With COVID-19
Reduction in death seen at 28, 60 days for patients receiving invasive mechanical ventilation, extracorporeal membrane oxygenation
U.S. Needs to Expand Naloxone Distribution
Modeling suggests community-based, pharmacy-initiated naloxone distribution more effective at averting opioid overdose deaths
SGLT2is, SGLT2i/GLP-1RA May Prevent CV Events in T2DM
Current use of SGLT2is, GLP-1RAs, and their combination associated with significantly reduced risk of heart failure events
Open-Label Placebo Studied in Children With Abdominal Pain, IBS
Open-label placebo may contribute to therapeutic effect in children and adolescents with functional abdominal pain, irritable bowel syndrome
Aromatase Inhibitors May Benefit Premenopausal Women With Breast Cancer
For premenopausal women receiving ovarian suppression, risk for breast cancer recurrence reduced with aromatase inhibitor versus tamoxifen
FDA Approves New Antibody Drug to Fight Omicron Variant
Emergency use authorization for bebtelovimab is for the treatment of mild-to-moderate COVID-19
FDA Panel Rejects Lilly Cancer Drug Tested Only in China
Drug was to be used alongside chemotherapy for patients with metastatic non-small cell lung cancer
U.S. Buys 600,000 Doses of New COVID-19 Treatment Still Awaiting FDA Approval
New drug will be distributed to states for free if it receives emergency use authorization from the FDA
Neoadjuvant Pembrolizumab Plus Chemo Treats Early TNBC
Rate of event-free survival higher with neoadjuvant pembrolizumab plus chemo versus chemo alone for early triple-negative breast cancer
Adding Tirzepatide to Insulin Glargine Ups Glycemic Control in T2DM
For adults with type 2 diabetes and inadequate glycemic control, glycemic control improved with addition of tirzepatide versus placebo
